UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cohen Klingenstein LLC

Cohen Klingenstein LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 37.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 17,200 shares of the healthcare conglomerate's stock after selling 10,500 shares during the period. Cohen Klingenstein LLC's holdings in UnitedHealth Group were worth $8,701,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the 3rd quarter worth about $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth approximately $32,000. Quarry LP grew its stake in shares of UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock worth $33,000 after acquiring an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the third quarter valued at $37,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UNH stock traded down $0.56 during trading on Friday, reaching $510.03. 7,462,712 shares of the company were exchanged, compared to its average volume of 5,104,531. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $469.37 billion, a P/E ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The stock's 50 day moving average price is $549.37 and its 200 day moving average price is $563.18.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 earnings per share. UnitedHealth Group's quarterly revenue was up 6.8% compared to the same quarter last year. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. StockNews.com lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Wednesday. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a report on Thursday, December 5th. Finally, Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of "Buy" and a consensus target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.